KONFIDENT Phase 3 Trial Global Expansion: Sebetralstat Pharmacokinetics and Pharmacodynamics in Japanese and Chinese AdultsHonda D, Iverson M, Hansen E, Hampton SL, Jhee S, Yoon E, Audhya PK, Smith MD, Yea CM, Hide M
APAAACI 2023
Investigating On-Demand Use of Oral Sebetralstat in Adults and Adolescents With Hereditary Angioedema: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 KONFIDENT Trial and Open-Label Extension DesignsHide M, Audhya PK, Smith MD, Yea CM
JSA 2023
Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstatCohn DM, Aygören-Pürsün E, Bernstein JA, Farkas H, Lumry WR, Maurer M, Zanichelli A, Iverson M, Hao J, Smith MD, Yea CM, Audhya PK, Riedl MA
2023 Clinical and Translation Allergy
Sebetralstat, Investigational Oral On-Demand Treatment for HAE: KONFIDENT Trial DesignAygören-Pürsün E, Zanichelli A, Cohn DM, Farkas H, Bernstein JA, Audhya PK, Smith MD, Yea CM, Lumry WR, Riedl MA, Maurer M
IWAA 2023
Short-Term Prophylaxis With Sebetralstat, an Investigational Oral On-Demand Treatment for Hereditary Angioedema, in KONFIDENT-SBernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM
IWAA 2023
Short-Term Prophylaxis with Sebetralstat, an Investigational Oral On-Demand Treatment for Hereditary Angioedema, in KONFIDENT-SBernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM
EAACI 2023
Results From a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial Evaluating Sebetralstat Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability in Healthy Japanese, Chinese, and White AdultsHide M, Iverson M, Jhee S, Hansen E, Duckworth EJ, Hampton SL, Yoon E, Honda D
EAACI 2023
Sebetralstat Effectiveness in the Treatment of Hereditary Angioedema Attacks Rated Mild or Moderate at Baseline in the Phase 2 TrialLonghurst HJ, Smith MD, Yea CM, Audhya PK
EAC 2023
Rationale for the Short-term Prophylaxis Regimen with Sebetralstat in KONFIDENT-SIverson M, Duckworth E, Hansen E, Hampton SL, Smith MD, Audhya PK, Yea CM
C1 Inhibitor Workshop 2023
Treatment with Sebetralstat Reduces the Cumulative Symptom Severity of Hereditary Angioedema Attacks in a Phase 2 TrialBernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM
AAAAI 2023
